Brief: Alfasigma To Acquire Intercept Pharmaceuticals For $19.00 Per Share In Cash

Intercept Pharmaceuticals

26/09/2023 13:03

Sept 26 (Reuters) - Intercept Pharmaceuticals Inc
 ICPT.O :
    * ALFASIGMA TO ACQUIRE INTERCEPT PHARMACEUTICALS FOR $19.00
PER
SHARE IN CASH, EXPANDING THE GLOBAL FOOTPRINT OF ALFASIGMA VIA A
LEADER IN RARE AND SERIOUS LIVER DISEASES
    * INTERCEPT PHARMACEUTICALS INC - TRANSACTION EXPECTED TO
CLOSE BY
END OF 2023
    * INTERCEPT : TRANSACTION WILL BE FULLY FINANCED BY
ALFASIGMA'S
EXISTING CASH ON HAND AND EXISTING CORPORATE CREDIT FACILITIES
    * INTERCEPT PHARMACEUTICALS INC - TRANSACTION WILL BE FULLY
FINANCED BY ALFASIGMA'S EXISTING CASH ON HAND AND EXISTING
CORPORATE CREDIT FACILITIES
    * INTERCEPT PHARMACEUTICALS INC - UPON COMPLETION OF
TRANSACTION,
INTERCEPT'S COMMON STOCK WILL NO LONGER BE PUBLICLY LISTED

Source text for Eikon:  ID:nGNX9ngKb6 
Further company coverage:  ICPT.O 

 ((Reuters.Briefs@thomsonreuters.com;))